37287063|t|P2X7 receptor inhibition ameliorates ubiquitin-proteasome system dysfunction associated with Alzheimer's disease.
37287063|a|BACKGROUND: Over recent years, increasing evidence suggests a causal relationship between neurofibrillary tangles (NFTs) formation, the main histopathological hallmark of tauopathies, including Alzheimer's disease (AD), and the ubiquitin-proteasome system (UPS) dysfunction detected in these patients. Nevertheless, the mechanisms underlying UPS failure and the factors involved remain poorly understood. Given that AD and tauopathies are associated with chronic neuroinflammation, here, we explore if ATP, one of the danger-associated molecules patterns (DAMPs) associated with neuroinflammation, impacts on AD-associated UPS dysfunction. METHODS: To evaluate if ATP may modulate the UPS via its selective P2X7 receptor, we combined in vitro and in vivo approaches using both pharmacological and genetic tools. We analyze postmortem samples from human AD patients and P301S mice, a mouse model that mimics pathology observed in AD patients, and those from the new transgenic mouse lines generated, such as P301S mice expressing the UPS reporter UbG76V-YFP or P301S deficient of P2X7R. RESULTS: We describe for the first time that extracellular ATP-induced activation of the purinergic P2X7 receptor (P2X7R) downregulates the transcription of beta5 and beta1 proteasomal catalytic subunits via the PI3K/Akt/GSK3/Nfr2 pathway, leading to their deficient assembly into the 20S core proteasomal complex, resulting in a reduced proteasomal chymotrypsin-like and postglutamyl-like activities. Using UPS-reported mice (UbGFP mice), we identified neurons and microglial cells as the most sensitive cell linages to a P2X7R-mediated UPS regulation. In vivo pharmacological or genetic P2X7R blockade reverted the proteasomal impairment developed by P301S mice, which mimics that were detected in AD patients. Finally, the generation of P301S;UbGFP mice allowed us to identify those hippocampal cells more sensitive to UPS impairment and demonstrate that the pharmacological or genetic blockade of P2X7R promotes their survival. CONCLUSIONS: Our work demonstrates the sustained and aberrant activation of P2X7R caused by Tau-induced neuroinflammation contributes to the UPS dysfunction and subsequent neuronal death associated with AD, especially in the hippocampus.
37287063	0	13	P2X7 receptor	Gene	18439
37287063	93	112	Alzheimer's disease	Disease	MESH:D000544
37287063	204	227	neurofibrillary tangles	Disease	MESH:D055956
37287063	229	233	NFTs	Disease	MESH:D055956
37287063	285	296	tauopathies	Disease	MESH:D024801
37287063	308	327	Alzheimer's disease	Disease	MESH:D000544
37287063	329	331	AD	Disease	MESH:D000544
37287063	352	362	proteasome	Disease	OMIM:256040
37287063	406	414	patients	Species	9606
37287063	530	532	AD	Disease	MESH:D000544
37287063	537	548	tauopathies	Disease	MESH:D024801
37287063	577	594	neuroinflammation	Disease	MESH:D000090862
37287063	616	619	ATP	Chemical	MESH:D000255
37287063	693	710	neuroinflammation	Disease	MESH:D000090862
37287063	723	725	AD	Disease	MESH:D000544
37287063	737	752	UPS dysfunction	Disease	OMIM:256040
37287063	778	781	ATP	Chemical	MESH:D000255
37287063	821	834	P2X7 receptor	Gene	18439
37287063	961	966	human	Species	9606
37287063	967	969	AD	Disease	MESH:D000544
37287063	970	978	patients	Species	9606
37287063	983	988	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
37287063	989	993	mice	Species	10090
37287063	997	1002	mouse	Species	10090
37287063	1043	1045	AD	Disease	MESH:D000544
37287063	1046	1054	patients	Species	9606
37287063	1090	1095	mouse	Species	10090
37287063	1121	1126	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
37287063	1127	1131	mice	Species	10090
37287063	1174	1179	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
37287063	1193	1199	P2X7R.	Gene	18439
37287063	1259	1262	ATP	Chemical	MESH:D000255
37287063	1300	1313	P2X7 receptor	Gene	18439
37287063	1315	1320	P2X7R	Gene	18439
37287063	1357	1362	beta5	Gene	122876
37287063	1367	1372	beta1	Gene	28905
37287063	1417	1420	Akt	Gene	11651
37287063	1421	1425	GSK3	Gene	56637
37287063	1621	1625	mice	Species	10090
37287063	1633	1637	mice	Species	10090
37287063	1723	1728	P2X7R	Gene	18439
37287063	1789	1794	P2X7R	Gene	18439
37287063	1853	1858	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
37287063	1859	1863	mice	Species	10090
37287063	1900	1902	AD	Disease	MESH:D000544
37287063	1903	1911	patients	Species	9606
37287063	1940	1945	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
37287063	1952	1956	mice	Species	10090
37287063	2101	2106	P2X7R	Gene	18439
37287063	2208	2213	P2X7R	Gene	18439
37287063	2224	2227	Tau	Gene	4137
37287063	2236	2253	neuroinflammation	Disease	MESH:D000090862
37287063	2273	2288	UPS dysfunction	Disease	OMIM:256040
37287063	2304	2318	neuronal death	Disease	MESH:D009410
37287063	2335	2337	AD	Disease	MESH:D000544
37287063	Association	MESH:D000544	RS#:63751438;HGVS:p.P301S;CorrespondingGene:4137
37287063	Association	MESH:D000255	11651
37287063	Negative_Correlation	18439	28905
37287063	Association	MESH:D009410	4137
37287063	Association	OMIM:256040	4137
37287063	Negative_Correlation	122876	18439
37287063	Association	MESH:D000255	MESH:D000090862
37287063	Association	11651	18439
37287063	Positive_Correlation	MESH:D000255	18439
37287063	Negative_Correlation	MESH:D000255	28905
37287063	Association	MESH:D000090862	4137
37287063	Association	MESH:D000544	18439
37287063	Negative_Correlation	MESH:D000255	122876
37287063	Association	MESH:D000255	56637
37287063	Association	MESH:D000544	4137

